SCHEMBL2479772

SCHEMBL2479772

CCOC(=O)CCN(CCCC(=O)OC)Cc1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.55
LTA4H P09960 6/20 0.48
BCHE P06276 1/20 0.47
ACHE P22303 1/20 0.47
TDP1 Q9NUW8 2/20 0.47
ALDH1A1 P00352 2/20 0.47
MAPK1 P28482 1/20 0.47
KMT2A Q03164 1/20 0.47
HDAC3 O15379 2/20 0.46
HDAC1 Q13547 2/20 0.46
HDAC2 Q92769 2/20 0.46
HDAC8 Q9BY41 2/20 0.46
NCOR2 Q9Y618 2/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
KDM4E B2RXH2 1/20 0.45
CYP3A4 P08684 1/20 0.44
CYP2D6 P10635 1/20 0.44
CYP2C19 P33261 1/20 0.44
MEP1B Q16820 1/20 0.43
TOP2A P11388 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL550428 0.95 ALOX5 (0.60) ALOX5LTA4HBCHEACHETDP1
SCHEMBL31301729 0.92 HDAC3 (0.52) ALOX5LTA4HBCHEACHETDP1
SCHEMBL1713228 0.92 ALOX5 (0.63) ALOX5LTA4HBCHEACHETDP1
SCHEMBL31301745 0.90 ALOX5 (0.52) ALOX5LTA4HBCHEACHETDP1
SCHEMBL30311604 0.90 ALOX5 (0.55) ALOX5LTA4HBCHEACHETDP1
SCHEMBL1836157 0.89 ALOX5 (0.63) ALOX5LTA4HBCHEACHETDP1
SCHEMBL25473056 0.89 HDAC3 (0.55) ALOX5LTA4HBCHEACHETDP1
SCHEMBL9324850 0.89 SMN1; SMN2 (0.55) ALOX5LTA4HBCHEACHETDP1
SCHEMBL18255136 0.87 TDP1 (0.49) ALOX5LTA4HBCHEACHETDP1
SCHEMBL15270589 0.86 HDAC3 (0.59) LTA4HBCHEACHETDP1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2376478-A2 PYRIDYLOXYINDOLES INHIBITORS OF VEGF-R2 AND USE THEREOF FOR TREATMENT OF DISEASE Novartis AG (CH) 2011-10-19 EP disclosed
WO-2010066684-A2 Pyridyloxyindoles Inhibitors of VEGF-R2 and Use Thereof for Treatment of Disease NOVARTIS AG (CH) 2010-06-17 WO disclosed